Invention Grant
- Patent Title: Targeting rare human PCSK9 variants for cholesterol treatment
-
Application No.: US14490160Application Date: 2014-09-18
-
Publication No.: US08999341B1Publication Date: 2015-04-07
- Inventor: Jasper Rupert Clube
- Applicant: Kymab Limited
- Applicant Address: GB Cambridge
- Assignee: Kymab Limited
- Current Assignee: Kymab Limited
- Current Assignee Address: GB Cambridge
- Agency: Nixon Peabody LLP, David S. Resnick
- Agent Leena H. Karttunen Contarino; Nicole Kling
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/40 ; A61K45/06
Abstract:
The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
Information query
